# A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis

> **NCT01044498** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 46 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tocilizumab
- **DRUG:** Ortho-Novum® 1/35

## Key facts

- **NCT ID:** NCT01044498
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2013-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01044498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01044498, "A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01044498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*